169 related articles for article (PubMed ID: 32586577)
1. Phosphatidylinositol-3-Kinase Inhibition in Follicular Lymphoma.
Lynch RC; Gopal AK
Hematol Oncol Clin North Am; 2020 Aug; 34(4):727-741. PubMed ID: 32586577
[TBL] [Abstract][Full Text] [Related]
2. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
Chin CK; Nastoupil LJ
Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
[TBL] [Abstract][Full Text] [Related]
3. The Role of PI3K Inhibition in Lymphoid Malignancies.
von Keudell G; Moskowitz AJ
Curr Hematol Malig Rep; 2019 Oct; 14(5):405-413. PubMed ID: 31359259
[TBL] [Abstract][Full Text] [Related]
4. Copanlisib: An Intravenous Phosphatidylinositol 3-Kinase (PI3K) Inhibitor for the Treatment of Relapsed Follicular Lymphoma.
Eltantawy A; Vallejos X; Sebea E; Evans K
Ann Pharmacother; 2019 Sep; 53(9):954-958. PubMed ID: 30813760
[No Abstract] [Full Text] [Related]
5. Immunomodulatory Agents in Follicular Lymphoma.
Ysebaert L; Morschhauser F
Hematol Oncol Clin North Am; 2020 Aug; 34(4):715-726. PubMed ID: 32586576
[TBL] [Abstract][Full Text] [Related]
6. Learnings from phosphatidylinositol 3-kinase inhibitors in lymphoma-Moving to a model where less can be more.
Martynchyk A; Hawkes EA
Br J Haematol; 2024 May; 204(5):1582-1584. PubMed ID: 38581289
[TBL] [Abstract][Full Text] [Related]
7. Copanlisib in the treatment of non-Hodgkin lymphoma.
Narkhede M; Cheson BD
Future Oncol; 2020 Sep; 16(26):1947-1955. PubMed ID: 32658557
[TBL] [Abstract][Full Text] [Related]
8. One Size Does Not Fit All: Who Benefits From Maintenance After Frontline Therapy for Follicular Lymphoma?
Roschewski M; Hill BT
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():467-476. PubMed ID: 31099693
[TBL] [Abstract][Full Text] [Related]
9. The role of obinutuzumab in the management of follicular lymphoma.
O'Nions J; Townsend W
Future Oncol; 2019 Nov; 15(31):3565-3578. PubMed ID: 31538821
[TBL] [Abstract][Full Text] [Related]
10. PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma.
Sapon-Cousineau V; Sapon-Cousineau S; Assouline S
Curr Treat Options Oncol; 2020 Apr; 21(6):51. PubMed ID: 32356174
[TBL] [Abstract][Full Text] [Related]
11. When to Use Targeted Therapy for the Treatment of Follicular Lymphoma.
Nastoupil LJ
Curr Hematol Malig Rep; 2021 Feb; 16(1):45-51. PubMed ID: 33797691
[TBL] [Abstract][Full Text] [Related]
12. Antibody Therapy Maintenance in Follicular Lymphoma.
Golfier C; Salles G
Hematol Oncol Clin North Am; 2020 Aug; 34(4):689-699. PubMed ID: 32586574
[TBL] [Abstract][Full Text] [Related]
13. Copanlisib for the treatment of adults with relapsed follicular lymphoma.
Magagnoli M; Carlo-Stella C; Santoro A
Expert Rev Clin Pharmacol; 2020 Aug; 13(8):813-823. PubMed ID: 32576028
[TBL] [Abstract][Full Text] [Related]
14. Novel agents for relapsed and refractory follicular lymphoma.
Cheah CY; Fowler NH
Best Pract Res Clin Haematol; 2018 Mar; 31(1):41-48. PubMed ID: 29452665
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directions.
Ng SY; Abramson JS
Curr Opin Hematol; 2016 Jul; 23(4):371-6. PubMed ID: 27213499
[TBL] [Abstract][Full Text] [Related]
16. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.
Procházka V; Papajík T; Janíková A; Belada D; Kozák T; Šálek D; Sýkorová A; Móciková H; Campr V; Dlouhá J; Langová K; Fürst T; Trněný M
Leuk Lymphoma; 2017 Mar; 58(3):601-613. PubMed ID: 27666539
[TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.
Alzahrani AS
Semin Cancer Biol; 2019 Dec; 59():125-132. PubMed ID: 31323288
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3 Kinase δ Inhibitors: Present and Future.
Brown JR
Cancer J; 2019; 25(6):394-400. PubMed ID: 31764120
[TBL] [Abstract][Full Text] [Related]
19. Early Progressing Follicular Lymphoma.
Wallace D; Casulo C
Curr Oncol Rep; 2021 Nov; 23(12):149. PubMed ID: 34797453
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in treatment of follicular lymphoma: efficacy of PI3Kα/δ inhibitor (TQ-B3525).
Watanabe T
Signal Transduct Target Ther; 2024 May; 9(1):134. PubMed ID: 38755160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
